The only vaccine to date specifically approved against monkeypox provides “strong protection” against the disease from the first dose, according to a new study. Two weeks after the first dose, the vaccine is estimated to be 78 percent effective. The vaccine is the vaccine from the German-Danish manufacturer Bavarian Nordic, which is also used in Austria. A second vaccination is given 28 days after the first dose.
“We now know that a first dose of vaccine provides strong protection against monkeypox,” said Jamie Lopez-Bernal, an epidemiologist at the UK Health Agency.
The findings are based on a study of 363 cases of monkeypox in England between July and November. According to the authority, this is the “strongest UK evidence to date” for the effectiveness of the vaccine.
“A second dose is expected to provide even greater and longer-lasting protection,” Lopez-Bernal said.
Until this year, the disease was mainly found in West and Central Africa, but since May it has also spread to other countries. However, numbers in Western Europe and North America, which have been particularly affected, have been declining for several months.
Source: Krone
I am an experienced and passionate journalist with a strong track record in news website reporting. I specialize in technology coverage, breaking stories on the latest developments and trends from around the world. Working for Today Times Live has given me the opportunity to write thought-provoking pieces that have caught the attention of many readers.
